S. mansoni-T. cruzi co-infection modulates arginase-1/iNOS expression, liver and heart disease in mice

Nitric Oxide - Biology and Chemistry

Volumn 66, Issue , 2017, Pages 43-52

  Rodrigues, João Paulo Ferreira ^a   Caldas, Ivo Santana ^a   Gonçalves, Reggiani Vilela ^b   Almeida, Leonardo Augusto ^a   Souza, Raquel Lopes Martins ^a   Novaes, Rômulo Dias ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Experimental pathology; Hepatic granuloma; Myocarditis; Nitric oxide; Parasitic diseases

Indexed keywords

ARGINASE 1; GAMMA INTERFERON; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE; TUMOR NECROSIS FACTOR; ARG1 PROTEIN, MOUSE; ARGINASE; CYTOKINE; NITRIC OXIDE SYNTHASE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD EXAMINATION; CHAGAS DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GRANULOMATOSIS; HEART DISEASE; HOST RESISTANCE; IMMUNOMODULATION; LIVER DISEASE; MIXED INFECTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PARASITEMIA; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TRYPANOSOMA CRUZI; ANIMAL; CARDIAC MUSCLE; DISEASE PREDISPOSITION; IMMUNOLOGY; LIVER; METABOLISM; MYOCARDITIS; PARASITIC LIVER DISEASE; PARASITOLOGY; PATHOLOGY;

ANIMALS; ARGINASE; CHAGAS DISEASE; COINFECTION; CYTOKINES; DISEASE SUSCEPTIBILITY; LIVER; LIVER DISEASES, PARASITIC; MICE; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TRYPANOSOMA CRUZI;

EID: 85014775875     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2017.02.013     Document Type: Article

References (43)

1. [1] Cox, F.E.G., Concomitant infections, parasites and immune responses. Parasitology 122 (2001), S23–S38.
2. [2] Brady, M.T., et al. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect. Immun. 67 (1999), 5372–5378.
3. [3] Loffredo-Verde, E., et al. Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype. Parasite Immunol. 37 (2015), 97–104.
4. [4] Cox, F.E.G., Concomitant infections, parasites and immune responses. Parasitology 122 (2001), S23–S38.
5. [5] Graham, A.L., Ecological rules governing helminth-microparasite coinfection. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 566–570.
6. [6] WHO, World Health Organization, Chagas Disease (American Trypanosomiasis). Updated March 2016, 2016 http://www.who.int/mediacentre/factsheets/fs340/en/.
7. [7] Bern, C., Chagas' disease. New Engl. J. Med. 373:5 (2015), 456–466.
8. [8] Colley, D.G., Bustinduy, A.L., Secor, W.E., King, C.H., Human schistosomiasis. Lancet 383 (2014), 2253–2264.
9. [9] WHO, World Health Organization, Schistosomiasis. Updated February 2016, 2016 http://www.who.int/mediacentre/factsheets/fs115/en/.
10. [10] Chuah, C., et al. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 30 (2014), 141–150.
11. [11] Teixeira, A.R.L., et al. Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin. Microb. Rev. 24 (2011), 592–630.
12. [12] Tendler, M., Pinto, R.M., Marcia, C., Gebara, G., Schistosoma mansoni: comparative evaluation of different routes of experimental infection. Rev. Inst. Med. Trop. S. Paulo 27 (1985), 111–114.
13. [13] Caldas, I.S., et al. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol. Res. 103 (2008), 413–421.
14. [14] Brener, Z., Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 4 (1962), 389–396.
15. [15] Novaes, R.D., Gonçalves, R.V., Penitente, A.R., Bozi, L.H., Neves, C.A., Maldonado, I.R., Natali, A.J., Talvani, A., Modulation of inflammatory and oxidative status by exercise attenuates cardiac morphofunctional remodeling in experimental Chagas cardiomyopathy. Life Sci., 152, 2016, 210 209.
16. [16] Lenzi, H.L., et al. Histoarchitecture of schistosomal granuloma development and involution: morphogenetic and biomechanical approaches. Mem. Inst. Oswaldo Cruz 93:S1 (1998), 141–151.
17. [17] Novaes, R.D., Curcumin enhances the anti-Trypanosoma cruzi activity of benznidazole-based chemotherapy in acute experimental Chagas disease. Antimicrob. Agents Chemother. 60:6 (2016), 3355–3364.
18. [18] Martinon, F., Chen, X., Lee, A.H., Glimcher, L.H., TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11 (2010), 411–418.
19. [19] Davis, M.J., et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio, 4, 2013, e00264 13.
20. [20] Hesse, M., Modolell, M., La Flamme, A.C., Schito, M., Fuentes, J.M., Cheever, A.W., Pearce, E.J., Wynn, T.A., Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167 (2001), 6533–6544.
21. [21] Munder, M., Eichmann, K., Modolell, M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160 (1998), 5347–5354.
22. [22] Tsikas, D., Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 15 (2007), 51–70.
23. [23] Cummings, K.L., Tarleton, R.L., Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129 (2003), 53–59.
24. [24] Santos, E.C., Novaes, R.D., Cupertino, M.C., Bastos, D.S., Klein, R.C., Silva, E.A., Fietto, J.L., Talvani, A., Bahia, M.T., Oliveira, L.L., Concomitant benznidazole and suramin chemotherapy in mice infected with a virulent strain of Trypanosoma cruzi. Antimicrob. Agents Chemother. 59 (2015), 5999–6006.
25. [25] Bustinduy, A., King, C., Scott, J., Appleton, S., Sousa-Figueiredo, J.C., Betson, M., Stothard, J.R., HIV and schistosomiasis co-infection in African children. Lancet. Infect. Dis. 14 (2014), 640–649.
26. [26] Secor, W.E., The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr. Opin. HIV AIDS 7 (2012), 254–259.
27. [27] Wolday, D., Mayaan, S., Mariam, Z.G., Berhe, N., Seboxa, T., Britton, S., Galai, N., Landay, A., Bentwich, Z., Treatment of intestinal worms is associated with decreased HIV plasma viral load. J. Acquir. Immun. Defic. Syndr. 31 (2002), 56–62.
28. [28] Brown, M., Miiro, G., Nkurunziza, P., Watera, C., Quigley, M.A., Dunne, D.W., Whitworth, J.A., Elliott, A.M., Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am. J. Trop. Med. Hyg. 74 (2006), 819–825.
29. [29] Elias, D., Mengistu, G., Akuffo, H., Britton, S., Are intestinal helminths risk factors for developing active tuberculosis?. Trop. Med. Int. Health 11 (2006), 551–558.
30. [30] Monin, L., Griffiths, K.L., Lam, W.Y., et al. Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. J. Clin. Invest. 125 (2015), 4699–4713.
31. [31] Helmby, H., Kullberg, M., Troye-Blomberg, M., Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66 (1998), 5167–5174.
32. [32] Booth, M., Vennervald, B.J., Kenty, L., et al. Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect. Dis, 4, 2004, 13.
33. [33] Diallo, T.O., Remoue, F., Schacht, A.M., et al. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol. 26 (2004), 365–369.
34. [34] Sokhna, C., Le Hesran, J.Y., Mbaye, P.A., et al. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar. J., 3, 2004, 43.
35. [35] Pearlman, E., Kazura, J.W., Hazlett, F.E. Jr., Boom, W.H., Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J. Immunol. 151 (1993), 4857–4864.
36. [36] Burke, M.L., et al. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 31 (2009), 163–176.
37. [37] Maizels, R.M., Yazdanbakhsh, M., Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 3 (2003), 733–744.
38. [38] Choromanski, L., Kuhn, R.E., Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease. Infect. Immun. 50 (1985), 354–357.
39. [39] Pearce, E.J., Caspar, P., Grzych, J.M., Lewis, F.A., Sher, A., Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173 (1991), 159–166.
40. [40] Yamashita, T., Boros, D.L., IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J. Immunol. 149 (1992), 3659–3664.
41. [41] Stempin, C.C., et al. Arginase in parasitic infections : macrophage activation, immunosuppression, and intracellular signals. J. Biomed. Biotechnol., 2010, 2010, 683485.
42. [42] Wu, G., Morris, S.M. Jr., Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998), 1–17.
43. [43] Yu, H., Yoo, P.K., Aguirre, C.C., Tsoa, R.W., Kern, R.M., Grody, W.W., Cederbaum, S.D., Iyer, R.K., Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J. Histochem. Cytochem 51 (2003), 1151–1160.